Grant: DRA : Canada Graduate Research Scholarship - Doctoral Program (CGRS D)
McGill University
$120,000.00
Defining molecular landscapes and tumor microenvironments in small cell carcinoma of the ovary, hypercalcemic type, to inform novel therapeutic strategies
FY 2025-26
Summary
Small cell carcinoma of the ovary, hypercalcemic type (SCCOHT) is a rare and highly aggressive cancer that primarily affects adolescents and young women. Despite surgery and multi-drug chemotherapy, survival rates remain very low. While some tumors respond well to immune-based or targeted therapies, these outcomes are often unpredictable, and the reasons behind this variability remain unclear. In addition, the biology of SCCOHT is poorly characterized, which limits the development of effective treatments.
The goal of this project is to improve our understanding of SCCOHT to inform novel therapeutic strategies. First, we will look at the tumour's DNA and study the RNA in individual cells to better understand the differences between tumour subtypes. This approach will help us understand why some tumors behave differently and identify features that could be targeted with therapies. Second, we will study the tumor microenvironment, including immune cells and supportive stromal cells, using advanced spatial techniques. This will reveal how tumors interact with surrounding cells, which can influence their growth, spread, and response to treatment. Third, we will perform systematic gene editing screens in SCCOHT cell lines to identify genes that, when blocked, selectively kill cancer cells. This concept, known as synthetic lethality, may highlight new, precise targets for therapy.
By combining these strategies, this project will define distinct molecular and morphological subgroups of SCCOHT, characterize their microenvironment, and uncover targetable vulnerabilities. These findings will provide a strong foundation for developing personalized therapies and improving outcomes for patients with this rare and deadly cancer. Ultimately, this work aims to advance both scientific knowledge and clinical care for young women affected by SCCOHT.
Department
Program
DRA : Canada Graduate Research Scholarship - Doctoral Program (CGRS D)
Recipient
Location
Quebec, Canada
Recipient Type
Academia
Type
Grant
Source
CIHR Funding Decisions Database
As published
Id
560230
Name
Diwan Sarah-Slim
Region
Québec
Country
Canada
Orgtype
Institution Paid; Research Institution
Instname2
Cancer Research
Theme2
Biomedical
Prcname2
DT1 (Biomedical and/or Clinical Research) CGRS Doctoral
Projecttitle
Defining molecular landscapes and tumor microenvironments in small cell carcinoma of the ovary, hypercalcemic type, to inform novel therapeutic strategies
Programtype2
Studentship Programs
Orgnameinp2
McGill University
Cihramount2
$120,000
Cihrequipment2
$0
Programname2
DRA : Canada Graduate Research Scholarship - Doctoral Program (CGRS D)
Keyworddelim
Gynecologic Tract; Ovarian Cancer; Single Nuclei Rna-Sequencing; Small Cell Carcinoma Of The Ovary Hypercalcemic Type; Smarca4; Spatial Transcriptomics; Swi/Snf Deficiency
Abstract
Small cell carcinoma of the ovary, hypercalcemic type (SCCOHT) is a rare and highly aggressive cancer that primarily affects adolescents and young women. Despite surgery and multi-drug chemotherapy, survival rates remain very low. While some tumors respond well to immune-based or targeted therapies, these outcomes are often unpredictable, and the reasons behind this variability remain unclear. In addition, the biology of SCCOHT is poorly characterized, which limits the development of effective treatments.
The goal of this project is to improve our understanding of SCCOHT to inform novel therapeutic strategies. First, we will look at the tumour's DNA and study the RNA in individual cells to better understand the differences between tumour subtypes. This approach will help us understand why some tumors behave differently and identify features that could be targeted with therapies. Second, we will study the tumor microenvironment, including immune cells and supportive stromal cells, using advanced spatial techniques. This will reveal how tumors interact with surrounding cells, which can influence their growth, spread, and response to treatment. Third, we will perform systematic gene editing screens in SCCOHT cell lines to identify genes that, when blocked, selectively kill cancer cells. This concept, known as synthetic lethality, may highlight new, precise targets for therapy.
By combining these strategies, this project will define distinct molecular and morphological subgroups of SCCOHT, characterize their microenvironment, and uncover targetable vulnerabilities. These findings will provide a strong foundation for developing personalized therapies and improving outcomes for patients with this rare and deadly cancer. Ultimately, this work aims to advance both scientific knowledge and clinical care for young women affected by SCCOHT.
Competitiondate
202511
Approvedterm2
3 yrs 0 mth
Pinamesdelim
Diwan, Sarah-Slim
Approvedterm
3 ans 0 mois
Cihrcontribution2
~ $120,000~ $0~